Respiratory interventions for breathlessness in adults with advanced diseases
Referencias
Additional references
Ameer F, Carson KV, Usmani ZA, Smith BJ. Ambulatory oxygen for people with chronic obstructive pulmonary disease who are not hypoxaemic at rest. Cochrane Database of Systematic Reviews 2014, Issue 6. [DOI: 10.1002/14651858.CD000238.pub2]
Cochrane Pain, Palliative and Supportive Care Group. PaPaS author and referee guidance (AUREF). papas.cochrane.org/papas‐documents (accessed 6 July 2016).
Bailey CD, Wagland R, Dabbour R, Caress A, Smith J, Molassiotis A. An integrative review of systematic reviews related to the management of breathlessness in respiratory illnesses. BMC Pulmonary Medicine 2010;10(63):1‐13. [DOI: 10.1186/1471‐2466‐10‐63]
Barnes H, McDonald J, Smallwood N, Manser R. Opioids for the palliation of refractory breathlessness in adults with advanced disease and terminal illness. Cochrane Database of Systematic Reviews 2016, Issue 3. [DOI: 10.1002/14651858.CD011008.pub2]
Barst RJ, McGoon M, Torbicki A, Sitbon O, Krowka MJ, Olschewski H, et al. Diagnosis and differential assessment of pulmonary arterial hypertension. Journal of the American College of Cardiology 2004;43(12):40‐7. [DOI: 10.1016/j.jacc.2004.02.032]
Booth S, Moosavi SH, Higginson IJ. The etiology and management of intractable breathlessness in patients with advanced cancer: a systematic review of pharmacological therapy. Nature Clinical Practice Oncology 2008;5(2):90‐100. [DOI: 10.1038/ncponc1034]
Booth S, Burkin J, Moffat C, Spathis A. Managing Breathlessness in Clinical Practice. London: Springer‐Verlag, 2014:396‐8. [DOI: 10.1007/978‐1‐4471‐4754‐1; ISBN 978‐1‐4471‐4754‐1]
Breaden K. Recent advances in the management of breathlessness. Indian Journal of Palliative Care 2011;17:29‐32. [PUBMED: 3140084]
Chin C, Booth S. Managing breathlessness: a palliative care approach. Postgraduate Medical Journal April 2016;92:393‐400. [DOI: 10.1136/postgradmedj‐2015‐133578]
Cranston JM, Crockett A, Currow D. Oxygen therapy for dyspnoea in adults. Cochrane Database of Systematic Reviews 2008, Issue 3. [DOI: 10.1002/14651858.CD004769.pub2]
Cristiano LM, Schwartzstein RM. Effect of chest wall vibration on dyspnea during hypercapnia and exercise in chronic obstructive pulmonary disease. American Journal of Respiratory & Critical Care Medicine 1997;155(5):1552‐9. [DOI: 10.1164/ajrccm.155.5.9154856]
Ferreira IM, Brooks D, White J, Goldstein R. Nutritional supplementation for stable chronic obstructive pulmonary disease. Cochrane Database of Systematic Reviews 2012, Issue 12. [DOI: 10.1002/14651858.CD000998.pub3]
Galbraith S, Fagan P, Perkins P, Lynch A, Booth S. Does the use of a handheld fan improve chronic dyspnea? ‐ A randomized, controlled, crossover trial. Journal of Pain and Symptom Management 2010;39(5):831–8. [DOI: 10.1016/j.jpainsymman.2009.09.024]
GRADE Working Group, McMaster University. GRADEpro GDT. Version accessed 01 July 2016. Hamilton (ON): GRADE Working Group, McMaster University, 2015.
Graham L. ACCP releases statement on dyspnea treatment in patients with advanced lung or heart disease. American Family Physician 2010;82(8):999‐1000.
Guz A. Brain, breathing and breathlessness. Respiration Physiology 1997;109(3):197–204.
Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org. Available from www.cochrane‐handbook.org. The Cochrane Collaboration.
Homma I, Obata T, Sibuya M, Uchida M. Gate mechanism in breathlessness caused by chest wall vibration in humans. Journal of Applied Physiology: Respiratory, Environmental & Exercise Physiology 1984;56(1):8‐11. [PUBMED: 6693337]
Johnson MJ, Currow DC, Booth S. Prevalence and assessment of breathlessness in the clinical setting. Expert Review of Respiratory Medicine 2014;8(2):151‐61. [DOI: 10.1586/17476348.2014.879530]
Lansing RW, Gracely RH, Banzett RB. The multiple dimensions of dyspnea: review and hypotheses. Respiratory Physiology & Neurobiology 2009;167(1):53‐60. [DOI: 10.1016/j.resp.2008.07.012]
Mahler DA. Opioids for refractory dyspnea. Expert Review of Respiratory Medicine 2013;7(2):123‐35. [DOI: 10.1586/ers.13.5]
McCarthy B, Casey D, Devane D, Murphy K, Murphy E, Lacasse Y. Pulmonary rehabilitation for chronic obstructive pulmonary disease. Cochrane Database of Systematic Reviews 2015, Issue 2. [DOI: 10.1002/14651858.CD003793.pub3]
Meek PM, Schwartzstein RM, Adams L, Altose MD, Breslin EH, Carrieri‐Kohlman V, et al. Dyspnea mechanisms, assessment, and management: a consensus statement. American Journal of Respiratory and Critical Care Medicine 1999;159(1):321–40. [DOI: 10.1164/ajrccm.159.1.ats898]
Moens K, Higginson IJ, Harding R. Are there differences in the prevalence of palliative care‐related problems in people living with advanced cancer and eight non‐cancer conditions? A systematic review. Journal of Pain and Symptom Management 2014;48(4):660‐77. [DOI: 10.1016/j.jpainsymman.2013.11.009]
Moher D, Liberati A, Tetzlaff J, Altman DG, the PRISMA Group. Preferred reporting items for systematic reviews and meta‐analyses: the PRISMA statement. PLoS Medicine 2009;6(7):e1000097. [DOI: 10.1371/journal.pmed.1000097]
Nield MA, Soo Hoo GW, Roper JM, Santiago S. Efficacy of pursed‐lips breathing: a breathing pattern retraining strategy for dyspnea reduction. Journal of Cardiopulmonary Rehabilitation & Prevention 2007;27(4):273‐44. [PUBMED: 17667021]
Parshall MB, Schwartzstein RM, Adams L, Banzett RB, Manning HL, Bourbeau J, et al. An official American Thoracic Society Statement: update on the mechanisms, assessment, and management of dyspnea. American Journal of Respiratory and Critical Care Medicine 2012;185(4):435–52. [DOI: 10.1164/rccm.201111‐2042ST]
Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager. Version 5.3. Copenhagen: Nordic Cochrane Centre, The Cochrane Collaboration, 2014.
Rohwer A, Booth A, Pfadenhauer L, Burns J, Brereton L, Gerhardus A, et al. Logic models help make sense of complexity in systematic reviews and health technology assessments. Journal of Clinical Epidemiology 2017;83:37‐47.
Sharp C, Adamali H, Millar AB. Ambulatory and short‐burst oxygen for interstitial lung disease. Cochrane Database of Systematic Reviews 2016, Issue 7. [DOI: 10.1002/14651858.CD011716.pub2]
Simon ST, Higginson IJ, Booth S, Harding R, Weingärtner V, Bausewein C. Benzodiazepines for the relief of breathlessness in advanced malignant and non‐malignant diseases in adults. Cochrane Database of Systematic Reviews 2016, Issue 10. [DOI: 10.1002/14651858.CD007354.pub3]
Solano JP, Gomes B, Higginson IJ. A comparison of symptom prevalence in far advanced cancer, AIDS, heart disease, chronic obstructive pulmonary disease and renal disease. Journal of Pain and Symptom Management 2006;31(1):58–69. [DOI: 10.1016/j.jpainsymman.2005.06.007]
Spahija JA, Grassino A. Effects of pursed‐lips breathing and expiratory resistive loading in healthy subjects. Journal of Applied Physiology 1996;80(5):1772‐84. [PUBMED: 8727566]
Spathis A, Booth S, Moffat C, Hurst R, Ryan R, Chin C, Burkin J. The Breathing, Thinking, Functioning clinical model: a proposal to facilitate evidence‐based breathlessness management in chronic respiratory disease. Primary Care Respiratory Medicine 2017;27. [DOI: 10.1038/s41533‐017‐0024‐z]
Teunissen SC, Wesker W, Kruitwagen C, de Haes HC, Voest EE, de Graeff A. Symptom prevalence in patients with incurable cancer: a systematic review. Journal of Pain and Symptom Management 2007;34(1):94‐104. [DOI: 10.1016/j.jpainsymman.2006.10.015]
References to other published versions of this review
Ir a:
Bausewein C, Booth S, Gysels M, Higginson IJ. Non‐pharmacological interventions for breathlessness in advanced stages of malignant and non‐malignant diseases. Cochrane Database of Systematic Reviews 2008, Issue 2. [DOI: 10.1002/14651858.CD005623.pub2]
Figuras y tablas -
Figure 2
System‐based logic model on respiration interventions for breathlessness in patients with advanced diseases
